Qol Holdings Co (TSE:3034) 3-Year EBITDA Growth Rate : 6.30% (As of Dec. 2023)

View and export this data going back to 2011. Start your Free Trial

What is Qol Holdings Co 3-Year EBITDA Growth Rate?

Qol Holdings Co's EBITDA per Share for the three months ended in Dec. 2023 was 円78.79.

During the past 12 months, Qol Holdings Co's average EBITDA Per Share Growth Rate was -7.20% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 6.30% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 5.20% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 8.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Qol Holdings Co was 73.10% per year. The lowest was -4.20% per year. And the median was 8.20% per year.

Competitive Comparison of Qol Holdings Co's 3-Year EBITDA Growth Rate

For the Pharmaceutical Retailers subindustry, Qol Holdings Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Qol Holdings Co's 3-Year EBITDA Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Qol Holdings Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Qol Holdings Co's 3-Year EBITDA Growth Rate falls into.

Qol Holdings Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Qol Holdings Co (TSE:3034) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Qol Holdings Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Qol Holdings Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Qol Holdings Co (TSE:3034) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Qol Holdings Co Ltd (TSE:3034) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

4-3-1, Toranomon, 37th Floor, Shiroyama Trust Tower, Minato-ku, Tokyo, JPN, 105-8452

Website

https://www.qolhd.co.jp

Qol Holdings Co Ltd provides pharmacy services under health insurance and sells pharmaceutical products. Its mission is to create healthy and comfortable living environments for everybody in those communities. The company operates through: Pharmacy and BPO segments. Under the Pharmacy segment the company puts customers first in-store development strategy, which is based on building one-on-one relationships with drug-prescribing clinics and hospitals in order to get the pharmacy services that include medical information. The BPO contracting segment includes clinical trials and projects and develops pamphlets and websites for medical institutions to promote sales of pharmaceutical products and provide advice on proper pharmaceutical product.

Qol Holdings Co (TSE:3034) Headlines

No Headlines